Actively Recruiting
Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic Version
Led by Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · Updated on 2025-11-21
270
Participants Needed
1
Research Sites
177 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
External Cephalic Version (ECV) is a maneuver to modify fetal position in pregnant women with a non-cephalic presentation. Its objective is to achieve a cephalic presentation that allows for vaginal delivery with less risk than a vaginal breech delivery or a cesarean section. ECV is an effective technique to reduce the rate of cesarean sections and is recommended by the Spanish Society of Obstetrics and Gynecology (SEGO) and the World Health Organization (WHO) Cesarean Section Working Group. The WHO aims to reduce interventionism in childbirth globally and implement non-clinical measures to reduce the rate of unnecessary cesarean sections. Despite Propofol is a sedative agent commonly used by anesthesiologist in countless ambulatory procedures in obstetric anaesthesia, it has been little studied in ECV, and its effect has not been compared with other commonly used agents such as remifentanil or spinal analgesia. The Obstetric Anesthesiology Section of the Spanish Society of Anesthesiology and Resuscitation recommends the use of locoregional analgesia in ECV.
CONDITIONS
Official Title
Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic Version
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntary participation
- Age 18 years or older
- Non-cephalic fetal presentation
- Desire to attempt vaginal birth
- Normal blood count and coagulation before the procedure
You will not qualify if you...
- Under 18 years of age
- Multiple pregnancies
- Baby in head-down position
- Risk of fetal compromise
- Unexplained active bleeding
- Absolute contraindication for vaginal delivery (Placenta Previa)
- Two or more previous cesarean sections
- Previous myomectomy with entry into the uterine cavity
- Maternal fever
- Low platelet count (less than 85,000 platelets)
- Maternal spinal abnormalities
- Allergy or intolerance to propofol or its components
- Allergy or intolerance to bupivacaine or its components
- Contraindication for intrathecal sedation or analgesia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Clínico Universitario Virgen de la Arrixaca
Murcia, Murcia, Spain, 30120
Actively Recruiting
Research Team
J
Javier Sanchez Romero, MD
CONTACT
C
Catalina De Paco Matallana, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here